Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
Practical guidance for dosing and switching from paliperidone palmitate 1 monthly to 3 monthly formulation in schizophrenia. [electronic resource] by
- Gopal, Srihari
- Vermeulen, An
- Nandy, Partha
- Ravenstijn, Paulien
- Nuamah, Isaac
- Buron Vidal, José Antonio
- Berwaerts, Joris
- Savitz, Adam
- Hough, David
- Samtani, Mahesh N
Producer: 20160608
In:
Current medical research and opinion vol. 31
Availability: No items available.
|
|
27.
|
Prospective dose selection and acceleration of paliperidone palmitate 3-month formulation development using a pharmacometric bridging strategy. [electronic resource] by
- Samtani, Mahesh N
- Nandy, Partha
- Ravenstijn, Paulien
- Remmerie, Bart
- Vermeulen, An
- Russu, Alberto
- D'hoore, Peter
- Baum, Ellen Z
- Savitz, Adam
- Gopal, Srihari
- Hough, David
Producer: 20171229
In:
British journal of clinical pharmacology vol. 82
Availability: No items available.
|
|
28.
|
Population pharmacokinetic analysis of abiraterone in chemotherapy-naïve and docetaxel-treated patients with metastatic castration-resistant prostate cancer. [electronic resource] by
- Stuyckens, Kim
- Saad, Fred
- Xu, Xu Steven
- Ryan, Charles J
- Smith, Matthew R
- Griffin, Thomas W
- Yu, Margaret K
- Vermeulen, An
- Nandy, Partha
- Poggesi, Italo
Producer: 20150708
In:
Clinical pharmacokinetics vol. 53
Availability: No items available.
|
|
29.
|
Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate-Treated Castration-Resistant Prostate Cancer Patients. [electronic resource] by
- Xu, Xu S
- Ryan, Charles J
- Stuyckens, Kim
- Smith, Matthew R
- Saad, Fred
- Griffin, Thomas W
- Park, Youn C
- Yu, Margaret K
- Vermeulen, An
- Poggesi, Italo
- Nandy, Partha
Producer: 20160510
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21
Availability: No items available.
|
|
30.
|
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome. [electronic resource] by
- Zhang, Liping
- Yan, Xiaoyu
- Nandy, Partha
- Willmann, Stefan
- Fox, Keith A A
- Berkowitz, Scott D
- Sharma, Amarnath
- Hermanowski-Vosatka, Anne
- Schmidt, Stephan
- Weitz, Jeffrey I
- Garmann, Dirk
- Peters, Gary
Producer: 20190813
In:
Therapeutic advances in cardiovascular disease vol. 13
Availability: No items available.
|
|
31.
|
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation. [electronic resource] by
- Zhang, Liping
- Yan, Xiaoyu
- Fox, Keith A A
- Willmann, Stefan
- Nandy, Partha
- Berkowitz, Scott D
- Hermanowski-Vosatka, Anne
- Weitz, Jeffrey I
- Solms, Alexander
- Schmidt, Stephan
- Patel, Manesh
- Peters, Gary
Producer: 20210409
In:
Journal of thrombosis and thrombolysis vol. 50
Availability: No items available.
|
|
32.
|
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer. [electronic resource] by
- Xu, Xu Steven
- Ryan, Charles J
- Stuyckens, Kim
- Smith, Matthew R
- Saad, Fred
- Griffin, Thomas W
- Park, Youn C
- Yu, Margaret K
- De Porre, Peter
- Vermeulen, An
- Poggesi, Italo
- Nandy, Partha
Producer: 20170816
In:
Clinical pharmacokinetics vol. 56
Availability: No items available.
|
|
33.
|
Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis. [electronic resource] by
- Timmers, Maarten
- Sinha, Vikash
- Darpo, Borje
- Smith, Brian
- Brown, Randy
- Xue, Hongqi
- Ferber, Georg
- Streffer, Johannes
- Russu, Alberto
- Tritsmans, Luc
- Solanki, Bhavna
- Bogert, Jennifer
- Van Nueten, Luc
- Salvadore, Giacomo
- Nandy, Partha
Producer: 20191126
In:
Journal of clinical pharmacology vol. 58
Availability: No items available.
|